Complement augments antibody neutralization of SARS-CoV-2 variants
Martin Groznica, Pierre Rosenbaum, Isabelle Staropoli, Florence Guivel‐Benhassine et autres
0 citationsScience Translational Medicine
Alexandre Gaymard
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
113Publications signalées
11162Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRespiratory viral infections researchSARS-CoV-2 detection and testingInfluenza Virus Research Studies
Publications récentes
Why Andes hantavirus is not the next SARS-CoV-2: contrasting viral shedding, transmissibility and genomic patterns
Antonin Bal, Virginie Sauvage, Maude Bouscambert‐Duchamp, B Lina et autres
0 citationsEurosurveillance
Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France
Slim Fourati, Slim Fourati, Alawiya Reslan, Jérôme Bourret et autres
6 citationsThe Lancet Microbe
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons
Astrid Marchal, Thibault Kerdiles, Aglaé Perrin, Adrian Gervais et autres
0 citationsThe Journal of Infectious Diseases
Immune dysregulation through longitudinal lymphocyte trajectories and their clinical determinants in hospitalized COVID-19 patients
José Pedro Cidade, Fabio Silvio Taccone, Luis Felipe Reyes, Laura Merson et autres
3 citationsIntensive Care Medicine Experimental
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in patients hospitalized with COVID-19: long-term results from the DisCoVeRy trial
Clément Massonnaud, Nathan Peiffer‐Smadja, Pascal Poignard, Simon Jamard et autres
1 citationClinical Microbiology and Infection
Urban environment and RSV: a retrospective observational study of neighbourhood factors associated with the risk of severe disease in the infant population of a metropolitan area, Lyon, France
Kaisa Jaakkola, Florent Renard, Álvaro Roy, Mehdi Benchaïb et autres
1 citationBMC Public Health
Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France
Cécile Chauvel, Jean‐Sébastien Casalegno, Benoît Visseaux, Vincent Vieillefond et autres
2 citationsJournal of Medical Virology
Rapid-sequence clinical research before and during a pandemic: Lessons learned and the way forward
Florence Ader, E. Aubret, Nathalie Bergaud, Maude Bouscambert-Duchamp et autres
0 citationsInfectious Diseases Now
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial
David M. Smadja, Clément Massonnaud, Aurélien Philippe, Mickaël Rosa et autres
7 citationsScientific Reports
Performance of Subgenomic RT‐PCR for Predicting SARS‐CoV‐2 Infectivity Compared to Genomic RT‐PCR and Culture Isolation
Célia Sentis, Delphine Parraud, G. Billaud, Martine Valette et autres
1 citationJournal of Medical Virology
Community and hospital-based laboratory surveillance for influenza, RSV, and SARS-CoV-2 during the 2023-2024 season, Lyon, France
Cécile Chauvel, Jean‐Sébastien Casalegno, Benoît Visseaux, Vincent Vieillefond et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.